LUX
Healthcare & Life Sciences
Transformation is the key to remaining competitive in healthcare and the life sciences.
With ageing populations, ever growing costs, and the rate of technological innovation skyrocketing, the Life Sciences and Healthcare industries are in the middle of enormous and disruptive changes.
The life sciences industry has been turned on its head as escalating research costs and patent losses forced big pharmaceutical players to aggressively pursue radical M&A strategies, whilst nimble biotech, medical device and diagnostics manufacturers are busy defining the next era of precision and targeted medicine - an era which has barely begun and one in which the need to be ever more innovative is a constant reality.
For healthcare providers, shrinking budgets and increasing expectations have created a challenging environment where payors and providers must reinvent the patient care model. Moreover, technological innovation and the developing role of the patient will drive transformation.
To thrive in this competitive and turbulent landscape, healthcare organisations and life sciences firms require exceptional leaders. Odgers Berndtson’s life sciences and healthcare practices support organisations in recruiting transformational leaders, with the ambition and strategic vision to pursue new opportunities.
Luxembourg
In Luxembourg, this sector, including hospitals, patient’s associations, service and capital providers, aims to strengthen and capitalise on the national strategy to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine. Personalised medicine is an area of expertise where the country has strong potential to be competitive at a global level.
We strongly hope that our global expertise, combined with valuable local advice and support, can help clients find the answers to face their talent challenges at a national level.
